Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome. (Q54589496)

1 June 2018

title

Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome. (English)

1 reference

1 June 2018

author name string

Seishima M

1

1 reference

1 June 2018

Yamanaka S

2

1 reference

1 June 2018

Fujisawa T

3

1 reference

1 June 2018

Tohyama M

4

1 reference

1 June 2018

Hashimoto K

5

1 reference

1 June 2018

language of work or name

English

0 references

publication date

1 August 2006

1 reference

1 June 2018

British Journal of Dermatology

published in

1 reference

1 June 2018

volume

155

1 reference

1 June 2018

issue

2

1 reference

1 June 2018

page(s)

344-349

1 reference

1 June 2018

Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07332.X

Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07332.X

Anticonvulsant hypersensitivity syndrome associated with reactivation of cytomegalovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07332.X

Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07332.X

Drug-induced hypersensitivity syndrome associated with cytomegalovirus reactivation: immunological characterization of pathogenic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07332.X

Human herpesvirus 6 and drug allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07332.X

Carbamazepine-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and reactivation of human herpesvirus 6 infection demonstrated by real-time quantitative polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07332.X

Drug-induced hypersensitivity syndrome due to cyanamide associated with multiple reactivation of human herpesviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07332.X

Drug-induced hypersensitivity syndrome due to mexiletine associated with human herpes virus 6 and cytomegalovirus reactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07332.X

Drug-induced hypersensitivity syndrome due to carbamazepine associated with reactivation of human herpesvirus 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07332.X

Virus reactivation and intravenous immunoglobulin (IVIG) therapy of drug-induced hypersensitivity syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07332.X

Modulating chemokines: more lessons from viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07332.X

In vitro activation of human herpesviruses 6 and 7 from latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2006.07332.X

10.1111/J.1365-2133.2006.07332.X

21 January 2018

Identifiers

DOI

1 reference

1 June 2018

1 reference

1 June 2018